Showing results (351-360 of 636) with videos related to

Sort By:
Pageof 64
Diabetes|January 1, 1995
Retinopathy, glucose, and insulin in an elderly population. The Rotterdam StudyR P Stolk, J R Vingerling, P T de Jong, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 1998
A prospective study on cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderlyS Kalmijn, L J Launer, R P Stolk, et al.
Cancer Treatment Reports|November 1, 1987
Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumorsG H Bakker, B Setyono-Han, M S Henkelman, et al.
Clinical Endocrinology|September 1, 1999
The continuous 7-hour intravenous dexamethasone suppression test in the differential diagnosis of ACTH-dependent Cushing's syndromeD P van den Bogaert, W W de Herder, F H de Jong, et al.
Digestion|January 1, 1993
111In-octreotide scintigraphy in oncologyE P Krenning, D J Kwekkeboom, J C Reubi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 24, 2001
Somatostatin receptor scintigraphy in the initial staging of low-grade non-Hodgkin's lymphomasP J Lugtenburg, B Löwenberg, R Valkema, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Progesterone, oestradiol, somatostatin and epidermal growth factor receptors on human meningiomas and their CT characteristicsT W Huisman, H L Tanghe, J W Koper, et al.
Bone|June 1, 1996
Hyperinsulinemia and bone mineral density in an elderly population: The Rotterdam StudyR P Stolk, P L Van Daele, H A Pols, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1992
Clinically nonfunctioning pituitary adenoma and octreotide response to long term high dose treatment, and studies in vitroT W de Bruin, D J Kwekkeboom, J W Van't Verlaat, et al.
Breast Cancer Research and Treatment|January 1, 1984
Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancerJ G Klijn, F H de Jong, M A Blankenstein, et al.
Pageof 64